cardiology

News in brief: DOACs less likely than warfarin to cause AKI; LVH a biomarker for cerebral atrophy; Top 10 Choosing Wisely recs for COVID-19

DOACs less likely than warfarin to cause AKI The risk of acute kidney injury (AKI) in elderly people with atrial fibrillation (AF) is lower with a DOAC (dabigatran, rivaroxaban, or apixaban) compared with warfarin, a Canadian study shows. A population-based cohort study of 20,683 outpatients with AF aged over 66 found that those who were ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic